Skip to content

Study · Case report or series · n = 1 · 2025

1 result

Semaglutide and laparoscopic sleeve gastrectomy in an adolescent with congenital adrenal hyperplasia due to 21-hydroxylase: a case report.

Vidmar AP, Kaiser L, Martin MJ, Abel S, Kim AG, Weitzner M, Muñoz CE, Fisher LK, Kim MS, Samakar K

Journal of medical case reports25 Jan 2025Cited by 1 (Europe PMC)

PMID39863876 (opens in a new tab)PMCIDPMC11765928 (opens in a new tab)DOI10.1186/s13256-025-05047-y (opens in a new tab)PepBankPUB-39863876
Read at sourcePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In an 18-year-old with congenital adrenal hyperplasia and class III obesity, semaglutide achieved an 11% BMI reduction.

    In plain wordsIn one young man with congenital adrenal hyperplasia and severe obesity, semaglutide lowered body mass index by 11%.

    Peptide
    Semaglutide
    Outcome
    DecreaseBMI reduction on semaglutide
    Study

    n = 1

    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated

    Measurements

    BMI reduction
    11%
    semaglutide

    Source sentences

    Summary
    Subsequently, he was treated with semaglutide, achieving an 11% body mass index reduction.
    1 context sentence
    Summary · context
    We present the case of an 18-year-old Hispanic male with classic congenital adrenal hyperplasia and class III obesity, who underwent a multimodal obesity treatment plan.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.